Cowen And Company, LLC Travere Therapeutics, Inc. Transaction History
Cowen And Company, LLC
- $0
- Q4 2024
A detailed history of Cowen And Company, LLC transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Cowen And Company, LLC holds 25,000 shares of TVTX stock, worth $370,750. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,000Holding current value
$370,750% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding TVTX
# of Institutions
214Shares Held
94.2MCall Options Held
1.2MPut Options Held
778K-
Black Rock Inc. New York, NY7.64MShares$113 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY7.36MShares$109 Million1.81% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.74MShares$100 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.97MShares$73.8 Million3.46% of portfolio
-
Macquarie Group LTD Australia, C34.26MShares$63.2 Million0.09% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $952M
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...